NHS Logo

Parkinson's disease : (Record no. 91053)

MARC details
000 -LEADER
fixed length control field 05056cam a2200637Mi 4500
001 - CONTROL NUMBER
control field ocn828140687
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240729131126.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |n|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 130220s2012 nyua ob 001 0 eng d
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
Canceled/invalid LC control number 2012470307
040 ## - CATALOGING SOURCE
Original cataloging agency YDXCP
019 ## -
-- 923653835
-- 1162046592
-- 1300652077
-- 1303349561
-- 1303400874
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1619428377
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781619428379
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9781619428300
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 161942830X
035 ## - SYSTEM CONTROL NUMBER
System control number 541059
-- (N$T)
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)828140687
Canceled/invalid control number (OCoLC)923653835
-- (OCoLC)1162046592
-- (OCoLC)1300652077
-- (OCoLC)1303349561
-- (OCoLC)1303400874
072 #7 - SUBJECT CATEGORY CODE
Subject category code HEA
Subject category code subdivision 039140
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 056000
Source bisacsh
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Parkinson's disease :
Subtitle diagnosis, treatment, and prognosis
Statement of responsibility, etc
Medium [E-Book]
260 ## - PUBLICATION INFORMATION
Place of publication New York :
Publisher Nova Science Publishers, Inc.,
Date [2012]
300 ## - PHYSICAL DESCRIPTION
Physical description 1 online resource (xii, 232 pages :
Other physical details illustrations).
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - SERIES TITLE
Series statement Neurodegenerative Diseases : Laboratory and Clinical Research
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - CONTENTS
Contents ""PARKINSON'S DISEASE ""; ""PARKINSON'S DISEASE ""; ""CONTENTS ""; ""PREFACE ""; ""THERAPEUTIC INTERVENTION AT CELLULAR CLEARANCE MECHANISMS: SIGNIFICANCE TO PARKINSON�a�?S DISEASE ""; ""ABSTRACT ""; ""ABBREVIATIONS ""; ""1. INTRODUCTORY REMARKS ""; ""2. INTRACELLULAR CLEARANCE MECHANISMS ""; ""2.1. The Ubiquitin Proteasome System ""; ""2.1.1. Quality Control through the Ubiquitin Proteasome System ""; ""2.1.2. Ubiquitin Proteasome System impairment in PD ""; ""2.2. The Autophagy-Lysosomal Pathway ""; ""2.2.1. Quality Control through the Autophagic- Lysosomal Pathway ""
505 8# - CONTENTS
Contents ""2.2.2. Autophagy- Lysosomal Pathway dysfunction in PD """"2.3. Enzymatic Proteolytic Systems ""; ""2.3.1. Quality Control through Cytosolic Proteolysis: Calpains ""; ""2.3.2. Quality Control through Mitochondrial Proteolysis: Lon, Clp-Like, AAA-Proteases ""; ""2.3.3. Enzymatic Proteolysis Disruption in PD ""; ""3. THERAPEUTIC INTERVENTIONS BASED ON THE MODULATION OF CLEARANCE MECHANISMS ""; ""3.1. Proteasomal Clearance �a�? A Target for Therapeutic Intervention ""; ""3.2. Autophagic Clearance �a�? A Target for Therapeutic Intervention ""
505 8# - CONTENTS
Contents ""3.3. Proteases Clearance �a�? A Target for Therapeutic Intervention """"CONCLUSION ""; ""ACKNOWLEDGMENTS ""; ""REFERENCES""; ""PARKINSON�a�?S DISEASE RELATED CHANGES OF OSCILLATORY ACTIVITY IN DISCRIMINATION TASKS ""; ""ABSTRACT ""; ""1. INTRODUCTION ""; ""2. METHODS ""; ""2.1. Experimental Procedure""; ""2.2. Analysis ""; ""3. EXPERIMENTAL RESULTS ""; ""Early (0�a�?250 ms) Post-stimulus Interval ""; ""Late (250�a�?600 ms) Post-stimulus Interval ""; ""4. DISCUSSION ""; ""CONCLUSION ""; ""REFERENCES ""
505 8# - CONTENTS
Contents ""NEW INSIGHTS INTO THE MECHANISM OF SLOWING OF VOLUNTARY MOVEMENTS IN PARKINSON�a�?S DISEASE """"ABSTRACT ""; ""ABBREVIATIONS ""; ""1. INTRODUCTION""; ""2. ANATOMIC ORGANIZATION OF THE BASAL GANGLIA ""; ""2.1. General Organization ""; ""2.2. Input and Output of Striatum and SNpc Connections ""; ""2.3. Input and Output of GP and SNpr, and STN Connections ""; ""2.4. Summary ""; ""3. PHYSIOLOGICAL FINDINGS OF THE BASAL GANGLIA IN ANIMALS ""; ""3.1. Neuronal Activity in Striatum, GPe and GPi ""; ""3.2. Neuronal Activity in STN, SNpc and SNpr ""
505 8# - CONTENTS
Contents ""3.3. Sequential Motor Actions and the Basal Ganglia""""3.4. Summary ""; ""4. CLINICAL SYMPTOMS OF PARKINSON�a�?S DISEASE ""; ""4.1. Slowness of Movement and Abnormal Movement Sequence ""; ""4.2. Impaired Synergy of Movement/Posture and Freezing, Loss of Postural Reflex and Festination""; ""4.3. Prolongation of Reaction Time ""; ""4.4. Reorganized Voluntary Eye Hand Coordinated Movement""; ""4.5. Impaired Time Perception and Reproduction ""; ""4.6. Summary ""; ""5. FUNCTIONAL CONSIDERATIONS OF SPATIO-TEMPORAL PROCESSING FOR MOVEMENT SYNERGY IN THE BASAL GANGLIA AND PARKINSON�a�?S DISEASE ""
546 ## - LANGUAGE NOTE
Language note English.
590 ## - LOCAL NOTE (RLIN)
Local note WorldCat record variable field(s) change: 650
650 #0 - SUBJECT HEADINGS
Subject term Parkinson's disease.
650 #0 - SUBJECT HEADINGS
Subject term Symptomatic Parkinson's disease.
650 #0 - SUBJECT HEADINGS
Subject term Brain
General subdivision Diseases.
650 #2 - SUBJECT HEADINGS
Subject term Brain Diseases
650 #2 - SUBJECT HEADINGS
Subject term Parkinson Disease
650 #2 - SUBJECT HEADINGS
Subject term Parkinson Disease, Secondary
700 1# - ADDED PERSONAL NAME
Added personal author Yoshida, Chiyo.
700 1# - ADDED PERSONAL NAME
Added personal author Ito, Ami.
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Neurodegenerative diseases--laboratory and clinical research.
856 ## - ONLINE RESOURCE
Uniform Resource Identifier <a href="#gotoholdings">#gotoholdings</a>
Link text Access resource
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Suppress in OPAC Do not Suppress in OPAC
588 0# - SOURCE OF DESCRIPTION NOTE
Source of description note Print version record.
938 ## -
-- ProQuest Ebook Central
-- EBLB
-- EBL3017811
938 ## -
-- ebrary
-- EBRY
-- ebr10654782
938 ## -
-- EBSCOhost
-- EBSC
-- 541059
938 ## -
-- YBP Library Services
-- YANK
-- 7422447
994 ## -
-- 92
-- N$T
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Total Checkouts Date last seen Uniform Resource Identifier Price effective from Koha item type
        Stenhouse Library (Kingston Hospital) Stenhouse Library (Kingston Hospital) Online 28/11/2022 eBook EBSCO clinical collection   28/11/2022 https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=541059 28/11/2022 Electronic book
London Health Libraries Consortium Privacy notice and Membership terms and conditions